New gene-editing system enables large-scale studies of gene function.
What are the different types of stem cells? Where do we stand in developing the promise of embryonic stem cells into therapies for patients? Hear some answers from Dr. George Daley of the MIT/Whitehead Institute for Biomedical Research and Massachusetts General Hospital.
Daley, a leading investigator in the development of stem cell therapies for blood disorders, will give a talk titled "Stem Cells: Medicine and Myth" today (Sept. 12) at 4:30 p.m. in Room 54-100.
Daley's work ranges from the basic science of embryonic and adult stem cells to the technological issues of making stem cells a therapeutic reality in clinical practice. He has served as an advisor to the federal government and has played an active role in the development of public policy for stem cell research.
Professor Douglas Lauffenburger, director of MIT's Biotechnology Process Engineering Center (BPEC), will introduce the lecture, providing the context for Daley's research at MIT.
Daley is a Fellow at the Whitehead Institute, a BPEC investigator and an assistant professor of medicine at MGH. The talk is hosted by the MIT student chapter of the Biomedical Engineering Society (BMES). It is part of the BMES-BPEC Distinguished Lecture Series.
A version of this article appeared in MIT Tech Talk on September 12, 2001.